Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
contig03601 |
glucose-6-phosphate dehydrogenase |
240 |
20 |
1.37E-11 |
95.35% |
3 |
P:glucose metabolic process; F:glucose-6-phosphate dehydrogenase activity; F:binding |
EC:1.1.1.49 |
|
contig03602 |
at rich interactive domain 1a (swi1 like) |
247 |
20 |
2.30E-35 |
91.00% |
7 |
C:SWI/SNF complex; F:protein binding; P:estrogen receptor signaling pathway; P:androgen receptor signaling pathway; F:transcription activator activity; P:chromatin organization; P:glucocorticoid receptor signaling pathway |
|
|
contig03603 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig03604 |
dihydrolipoamide s-succinyltransferase (e2 component of 2-oxo-glutarate complex) |
338 |
20 |
2.62E-39 |
78.05% |
5 |
C:oxoglutarate dehydrogenase complex; F:dihydrolipoyllysine-residue succinyltransferase activity; F:protein binding; P:tricarboxylic acid cycle; F:lipoic acid binding |
EC:2.3.1.61 |
|
contig03605 |
---NA--- |
241 |
0 |
|
|
0 |
|
|
|
contig03606 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig03607 |
mu-2 related death-inducing protein |
281 |
20 |
6.46E-30 |
90.85% |
6 |
P:protein complex assembly; F:protein binding; F:protein transporter activity; P:vesicle-mediated transport; P:intracellular protein transport; C:clathrin adaptor complex |
|
|
contig03608 |
serine hydroxymethyltransferase 1 |
966 |
20 |
4.82E-72 |
89.20% |
6 |
F:pyridoxal phosphate binding; P:one-carbon metabolic process; P:L-serine metabolic process; F:glycine hydroxymethyltransferase activity; P:glycine metabolic process; C:mitochondrion |
EC:2.1.2.1 |
|
contig03609 |
ankyrin repeat domain 13c |
294 |
20 |
3.60E-36 |
92.15% |
2 |
F:F; P:P |
|
|
contig03610 |
calcium activated nucleotidase isoform cra_b |
1023 |
20 |
1.09E-66 |
82.10% |
11 |
F:uridine-diphosphatase activity; F:calcium ion binding; F:signal transducer activity; C:integral to membrane; C:membrane fraction; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; C:extracellular region; C:endoplasmic reticulum membrane; C:Golgi apparatus; F:guanosine-diphosphatase activity; P:ribonucleoside diphosphate catabolic process |
EC:3.6.1.42 |
|
contig03611 |
---NA--- |
305 |
0 |
|
|
0 |
|
|
|
contig03612 |
nol1 nop2 sun domain member 2 |
939 |
20 |
1.18E-35 |
94.95% |
5 |
C:cytoplasm; F:tRNA (cytosine-5-)-methyltransferase activity; C:nucleus; P:tRNA processing; F:tRNA binding |
EC:2.1.1.29 |
|
contig03613 |
---NA--- |
400 |
0 |
|
|
0 |
|
|
|
contig03614 |
argininosuccinate lyase |
297 |
20 |
1.70E-26 |
89.80% |
13 |
P:response to hypoxia; P:arginine catabolic process; P:liver development; F:argininosuccinate lyase activity; P:response to nutrient; P:arginine biosynthetic process via ornithine; P:urea cycle; P:response to peptide hormone stimulus; P:response to glucocorticoid stimulus; P:kidney development; C:cytoplasm; P:response to cAMP; P:argininosuccinate metabolic process |
EC:4.3.2.1 |
|
contig03615 |
asparagine synthetase |
475 |
20 |
3.19E-77 |
94.20% |
7 |
P:positive regulation of mitotic cell cycle; C:soluble fraction; P:glutamine metabolic process; P:cellular response to glucose starvation; P:asparagine biosynthetic process; F:asparagine synthase (glutamine-hydrolyzing) activity; P:negative regulation of apoptosis |
EC:6.3.5.4 |
|
contig03616 |
suppressor of cytokine signaling 9 |
876 |
20 |
1.46E-100 |
87.65% |
9 |
P:positive regulation of T-helper 1 cell differentiation; P:negative regulation of signal transduction; P:regulation of cell growth; P:negative regulation of T-helper 2 cell differentiation; P:ubiquitin cycle; P:cytokine-mediated signaling pathway; ; P:epidermal growth factor receptor signaling pathway; F:epidermal growth factor receptor binding |
|
|
contig03617 |
nuclear rna export factor 1 |
383 |
5 |
1.09E-08 |
60.40% |
3 |
F:nucleotide binding; C:intracellular; P:transport |
|
|
contig03618 |
---NA--- |
247 |
0 |
|
|
0 |
|
|
|
contig03619 |
---NA--- |
1163 |
0 |
|
|
0 |
|
|
|
contig03620 |
---NA--- |
341 |
0 |
|
|
0 |
|
|
|
contig03621 |
---NA--- |
466 |
0 |
|
|
0 |
|
|
|
contig03622 |
cytochrome c oxidase subunit mitochondrial precursor |
421 |
20 |
6.35E-57 |
88.60% |
4 |
P:electron transport; P:embryonic organ development; P:spinal cord motor neuron differentiation; F:cytochrome-c oxidase activity |
EC:1.9.3.1 |
|
contig03623 |
wd repeat domain 85 |
241 |
20 |
1.83E-32 |
72.00% |
2 |
F:F; P:P |
|
|
contig03624 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig03625 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig03626 |
wd repeat domain 36 |
401 |
20 |
4.54E-55 |
77.70% |
4 |
P:response to stimulus; C:small-subunit processome; P:rRNA processing; P:visual perception |
|
|
contig03627 |
---NA--- |
385 |
0 |
|
|
0 |
|
|
|
contig03628 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig03629 |
transmembrane protein 147 |
361 |
20 |
3.42E-55 |
96.70% |
2 |
C:membrane attack complex; F:protein binding |
|
|
contig03630 |
dihydrolipoamide s-succinyltransferase (e2 component of 2-oxo-glutarate complex) |
469 |
20 |
7.51E-34 |
97.25% |
6 |
C:oxoglutarate dehydrogenase complex; F:dihydrolipoyllysine-residue succinyltransferase activity; F:protein binding; P:tricarboxylic acid cycle; F:lipoic acid binding; C:mitochondrion |
EC:2.3.1.61 |
|
contig03631 |
fumarate hydratase |
684 |
20 |
2.64E-109 |
95.30% |
7 |
C:tricarboxylic acid cycle enzyme complex; P:homeostasis of number of cells within a tissue; P:fumarate metabolic process; P:tricarboxylic acid cycle; C:mitochondrion; P:negative regulation of cell cycle; F:fumarate hydratase activity |
EC:4.2.1.2 |
|
contig03632 |
synovial x breakpoint 2 interacting protein |
353 |
12 |
3.50E-15 |
64.67% |
7 |
C:protein complex; P:cell adhesion; C:cell junction; P:P; F:protein binding; C:nucleus; C:C |
|
|
contig03633 |
---NA--- |
425 |
0 |
|
|
0 |
|
|
|
contig03634 |
breast cancer resistance protein |
279 |
2 |
7.43E-10 |
71.00% |
0 |
|
|
|
contig03635 |
---NA--- |
251 |
0 |
|
|
0 |
|
|
|
contig03636 |
---NA--- |
312 |
0 |
|
|
0 |
|
|
|
contig03637 |
---NA--- |
533 |
0 |
|
|
0 |
|
|
|
contig03638 |
unnamed protein product [Tetraodon nigroviridis] |
318 |
1 |
6.24E-04 |
48.00% |
0 |
|
|
|
contig03639 |
fukutin |
620 |
20 |
7.55E-27 |
85.25% |
6 |
C:Golgi membrane; C:extracellular space; P:muscle organ development; P:nervous system development; F:transferase activity; C:integral to membrane |
|
|
contig03640 |
zinc finger protein 330 |
432 |
20 |
7.48E-10 |
85.45% |
5 |
C:nucleolus; C:chromosome, centromeric region; C:midbody; F:zinc ion binding; F:protein binding |
|
|
contig03641 |
---NA--- |
176 |
0 |
|
|
0 |
|
|
|
contig03642 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig03643 |
minichromosome maintenance complex component 2 |
302 |
20 |
2.50E-13 |
73.95% |
12 |
P:regulation of DNA replication initiation; F:zinc ion binding; P:cell cycle; P:regulation of transcription, DNA-dependent; P:DNA unwinding involved in replication; C:MCM complex; F:DNA binding; F:ATP binding; C:chromatin; F:DNA-dependent ATPase activity; P:retina development in camera-type eye; F:chromatin binding |
|
|
contig03644 |
coiled-coil-helix-coiled-coil-helix domain containing 5 |
704 |
20 |
4.34E-46 |
71.95% |
2 |
F:F; P:P |
|
|
contig03645 |
ubiquitin specific peptidase 5 (isopeptidase t) |
252 |
20 |
2.31E-06 |
97.15% |
15 |
F:ubiquitin thiolesterase activity; F:cysteine-type endopeptidase activity; F:hydrolase activity; F:zinc ion binding; C:lysosome; C:proteasome complex; P:ubiquitin cycle; C:C; P:ubiquitin-dependent protein catabolic process; F:ubiquitin-specific protease 5 activity; F:peptidase activity; F:protein binding; F:metal ion binding; F:endopeptidase inhibitor activity; F:calcium ion binding |
|
|
contig03646 |
coiled-coil-helix-coiled-coil-helix domain-containing protein 1 |
264 |
4 |
7.31E-13 |
85.00% |
0 |
|
|
|
contig03647 |
glycogen phosphorylase |
250 |
20 |
3.66E-25 |
92.30% |
2 |
F:pyridoxal phosphate binding; F:phosphorylase activity |
EC:2.4.1.1 |
|
contig03648 |
---NA--- |
337 |
0 |
|
|
0 |
|
|
|
contig03649 |
nuclear protein 1 |
778 |
20 |
4.39E-24 |
80.00% |
3 |
P:induction of apoptosis; P:cell growth; C:nucleus |
|
|
contig03650 |
subfamily member 17 |
577 |
20 |
1.57E-57 |
84.55% |
5 |
P:protein folding; F:RNA binding; F:unfolded protein binding; F:nucleotide binding; F:heat shock protein binding |
|
|
contig03651 |
cdc6-related protein |
647 |
20 |
4.02E-53 |
61.10% |
2 |
F:binding; C:intracellular organelle |
|
|
contig03652 |
---NA--- |
455 |
0 |
|
|
0 |
|
|
|
contig03653 |
---NA--- |
327 |
0 |
|
|
0 |
|
|
|
contig03654 |
comm domain containing 5 |
476 |
20 |
5.67E-50 |
77.75% |
4 |
C:nucleus; P:cell cycle arrest; F:protein binding; P:regulation of cell differentiation |
|
|
contig03655 |
abc1 activity of bc1 complex like ( pombe) |
297 |
20 |
1.08E-24 |
85.10% |
4 |
P:protein amino acid phosphorylation; F:protein kinase activity; F:ATP binding; C:mitochondrion |
|
|
contig03656 |
---NA--- |
217 |
0 |
|
|
0 |
|
|
|
contig03657 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
contig03658 |
---NA--- |
303 |
0 |
|
|
0 |
|
|
|
contig03659 |
novel protein dipeptidyl-peptidase 9 ( zgc:152900) |
340 |
9 |
4.59E-14 |
86.44% |
4 |
F:copper ion binding; F:dipeptidyl-peptidase IV activity; C:membrane; F:electron carrier activity |
EC:3.4.14.5 |
|
contig03660 |
etoposide induced mrna |
267 |
20 |
1.05E-19 |
92.95% |
1 |
P:induction of apoptosis |
|
|
contig03661 |
---NA--- |
364 |
0 |
|
|
0 |
|
|
|
contig03662 |
---NA--- |
245 |
0 |
|
|
0 |
|
|
|
contig03663 |
---NA--- |
268 |
0 |
|
|
0 |
|
|
|
contig03664 |
phosphatidylinositol transfer alpha |
708 |
20 |
1.27E-85 |
83.15% |
11 |
F:phosphatidylinositol transporter activity; P:lipid metabolic process; C:integral to membrane; F:phospholipid binding; P:phospholipid transport; P:visual perception; F:protein binding; P:axonogenesis; F:phosphatidylcholine transmembrane transporter activity; P:in utero embryonic development; C:Golgi apparatus |
|
|
contig03665 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
contig03666 |
---NA--- |
113 |
0 |
|
|
0 |
|
|
|
contig03667 |
transmembrane protein 44 |
269 |
1 |
7.80E-07 |
61.00% |
2 |
P:P; C:C |
|
|
contig03668 |
---NA--- |
272 |
0 |
|
|
0 |
|
|
|
contig03669 |
zinc finger hit domain-containing protein 4 |
253 |
3 |
1.11E-08 |
88.00% |
2 |
F:F; C:C |
|
|
contig03670 |
t-cell immune regulator 1 |
275 |
20 |
7.94E-30 |
79.85% |
4 |
C:membrane; C:cytoplasm; F:hydrolase activity; P:proton transport |
|
|
contig03671 |
---NA--- |
312 |
0 |
|
|
0 |
|
|
|
contig03672 |
---NA--- |
693 |
0 |
|
|
0 |
|
|
|
contig03673 |
---NA--- |
127 |
0 |
|
|
0 |
|
|
|
contig03674 |
---NA--- |
262 |
0 |
|
|
0 |
|
|
|
contig03675 |
---NA--- |
409 |
0 |
|
|
0 |
|
|
|
contig03676 |
cappuccino homolog |
1011 |
5 |
1.10E-13 |
81.60% |
2 |
F:F; P:P |
|
|
contig03677 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
contig03678 |
translocase of inner mitochondrial membrane 44 homolog |
240 |
20 |
5.34E-24 |
96.50% |
6 |
F:P-P-bond-hydrolysis-driven protein transmembrane transporter activity; C:mitochondrial inner membrane presequence translocase complex; P:protein targeting to mitochondrion; F:ATP binding; P:intracellular protein transmembrane transport; C:mitochondrial matrix |
|
|
contig03679 |
---NA--- |
714 |
0 |
|
|
0 |
|
|
|
contig03680 |
beta-galactoside-binding lectin precursor |
414 |
20 |
1.22E-20 |
67.20% |
8 |
P:regulation of apoptosis; C:cytoplasm; F:sugar binding; C:extracellular space; F:signal transducer activity; P:myoblast differentiation; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; F:protein homodimerization activity |
|
|
contig03681 |
---NA--- |
744 |
0 |
|
|
0 |
|
|
|
contig03682 |
heavy chain non-muscle |
347 |
20 |
2.99E-14 |
87.20% |
43 |
P:angiogenesis; C:cortical cytoskeleton; P:sensory perception of sound; P:regulation of cell shape; C:neuromuscular junction; P:actin filament-based movement; F:actin-dependent ATPase activity; P:establishment of meiotic spindle localization; C:cell-cell adherens junction; P:cell-cell adhesion; F:ADP binding; P:protein transport; C:immunological synapse; P:leukocyte migration; P:integrin-mediated signaling pathway; C:cytosol; P:myoblast fusion; F:microfilament motor activity; P:membrane protein ectodomain proteolysis; P:blood vessel endothelial cell migration; C:integrin complex; C:spindle; C:ruffle; P:meiotic metaphase I; C:cleavage furrow; P:meiotic spindle organization; P:establishment of T cell polarity; F:protein anchor; F:actin filament binding; C:stress fiber; C:uropod; P:cell morphogenesis involved in differentiation; F:protein homodimerization activity; P:actin cytoskeleton reorganization; P:platelet formation; P:monocyte differentiation; F:calmodulin binding; C:nucleus; F:ATP binding; C:actomyosin contractile ring; P:in utero embryonic development; C:myosin complex; P:cytokinesis |
|
|
contig03683 |
thimet oligopeptidase 1 |
536 |
20 |
8.34E-86 |
81.40% |
11 |
P:intracellular protein kinase cascade; F:metalloendopeptidase activity; F:mitochondrial inner membrane peptidase activity; F:protein binding; P:zinc ion transport; F:metalloendopeptidase inhibitor activity; P:peptide metabolic process; P:proteolysis; F:zinc ion binding; C:cytosol; C:mitochondrion |
EC:3.4.24.0 |
|
contig03684 |
---NA--- |
269 |
0 |
|
|
0 |
|
|
|
contig03685 |
zinc cchc domain containing 9 |
267 |
20 |
1.73E-14 |
91.60% |
2 |
F:zinc ion binding; F:nucleic acid binding |
|
|
contig03686 |
---NA--- |
298 |
0 |
|
|
0 |
|
|
|
contig03687 |
---NA--- |
287 |
0 |
|
|
0 |
|
|
|
contig03688 |
wd repeat and hmg-box dna binding protein 1 |
423 |
20 |
8.91E-27 |
61.45% |
4 |
P:regulation of transcription, DNA-dependent; C:cytoplasm; F:DNA binding; C:nucleus |
|
|
contig03689 |
g-protein coupled receptor |
724 |
20 |
5.93E-118 |
52.00% |
2 |
P:G-protein coupled receptor protein signaling pathway; F:rhodopsin-like receptor activity |
|
|
contig03690 |
---NA--- |
270 |
0 |
|
|
0 |
|
|
|
contig03691 |
squamous cell carcinoma antigen recognized by t-cells 1 |
285 |
20 |
1.63E-44 |
91.65% |
7 |
P:cell cycle arrest; C:cytosol; P:positive regulation of cytotoxic T cell differentiation; P:RNA splicing; P:induction of apoptosis by intracellular signals; C:spliceosomal complex; P:mRNA processing |
|
|
contig03692 |
---NA--- |
470 |
0 |
|
|
0 |
|
|
|
contig03693 |
platelet-activating factor isoform alpha subunit |
246 |
20 |
2.80E-41 |
95.40% |
32 |
C:nonmotile primary cilium; P:neuron migration; P:retrograde axon cargo transport; P:apical protein localization; P:learning or memory; P:lipid catabolic process; F:phosphoprotein binding; C:nuclear membrane; P:hippocampus development; P:photoreceptor cell maintenance; P:neuroblast proliferation; F:hydrolase activity; P:cell division; P:acrosome assembly; C:microtubule; P:layer formation in the cerebral cortex; C:motile primary cilium; P:vesicle transport along microtubule; F:microtubule binding; C:spindle; P:mitosis; C:centrosome; P:synaptic transmission; P:microtubule cytoskeleton organization; P:neuromuscular process controlling balance; C:microtubule associated complex; P:actin cytoskeleton organization; C:perinuclear region of cytoplasm; F:protein homodimerization activity; C:cell leading edge; P:regulation of Rho GTPase activity; P:adult locomotory behavior |
|
|
contig03694 |
---NA--- |
259 |
0 |
|
|
0 |
|
|
|
contig03695 |
3-oxoacyl-acyl-carrier-protein reductase |
488 |
20 |
1.67E-49 |
80.10% |
3 |
F:oxidoreductase activity; P:metabolic process; F:binding |
|
|
contig03696 |
---NA--- |
469 |
0 |
|
|
0 |
|
|
|
contig03697 |
heterogeneous nuclear ribonucleoprotein m |
428 |
20 |
2.67E-31 |
87.25% |
1 |
F:antigen binding |
|
|
contig03698 |
---NA--- |
250 |
0 |
|
|
0 |
|
|
|
contig03699 |
prp4 pre-mrna processing factor 4 homolog |
270 |
20 |
5.92E-23 |
98.10% |
7 |
P:response to oxidative stress; C:U4/U6 x U5 tri-snRNP complex; ; C:spliceosomal complex; F:heme binding; C:nuclear speck; P:nuclear mRNA splicing, via spliceosome |
|
|
contig03700 |
---NA--- |
429 |
0 |
|
|
0 |
|
|
|
100 Rows returned.